illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. health care
  6. ›
  7. Nano x Imaging
Company logo

Nano x Imaging | Sustainability Performance

https://www.nanox.vision/

Develops and manufactures medical imaging systems, including a digital X-ray source and cloud-based software for medical screening.

2011

Israel

51 - 200 employees

Medical Device

$10M - 25M in revenue

Not profitable

Submit or report inaccurate dataDownload Company Insights

Sustainability Ranking & Industry Benchmark

#6593
Overall
#17
in Israel
#100
in Medical Device

Sustainability Maturity

​​0123456789​​%

Sustainability Intent

Available in
Scale package

Access
​​0123456789​​%

Beyond Top 100

Overview
Governance
TargetsESG scores and Exclusions
Financial Data
Business performanceCapital & innovationAnalyst projectionsAsset manager exclusion

View similiar companies


Company logo
Sisram Medical

Israel, Health Care, Medical Device


Company logo
Teva Pharmaceuticals

Israel, Health Care, Pharmaceuticals


Company logo
Taro Pharmaceutical industries

Israel, Health Care, Pharmaceuticals

Market cap

124.0M $, 2026▲218.6% YoY

Revenue

11.0M $, 2024▼18.2% YoY

R&D intensity

181.82% 2024

Controversy level


Very Low
Low
Noticeable
High
Severe
Download Controversy Analysis
Powered by illuminem

Market cap

124.0M $, 2026▲218.6% YoY

Revenue

11.0M $, FY2024▼18.2% YoY

EBITDA

-56.0M $, FY2024▼9.1% YoY

Operating margin

-500% Industry: -147▲6.3% YoY

Revenue & EBITDA

$11.0MFY2024 revenue

Total Annual
Revenue & EBITDA
($ B)

Annual revenue
EBITDA
3 year change
Powered by illuminem

Margin trends


Margin as % of revenue

Gross margin
Operating margin
Net margin

Powered by illuminem

Free cashflow

-39.4M 2024▲22.1% YoY

Capex

2.0M 2024▲50% YoY

Debt/equity ratio

0.0 Industry: 1▼NaN% YoY

R&D intensity

181.8%FY2024

R&D as % of revenue

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Return on invested capital

-28.0%FY2026

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Analyst revenue estimates & actuals


Analyst consensus vs actuals
($ B)

Actual revenue
Consensus estimates
Estimate only

0.0

▼ 13.5%

2022

0.0

▼ 14.5%

2023

0.0

▼ 9.3%

2024

0.4

2031

Powered by illuminem

Asset manager exclusions

1 2026▼NaN% YoY

Exclusions by region

Reveal data for 2 credits

Institutions excluding by region out of total tracked institutions

Powered by illuminem and Covalence

Excluding institutions

Reveal data for 2 credits

Institution name, type, screener label

Powered by illuminem and Covalence

Environmental policy coverage

Carbon reduction policy

Not available

Human rights policy

Not available

Recycling policy

Not available

Workplace health & safety policy

Available

36%
Independent Directors

5 out of 14 incl. management

Powered by illuminem

Overall score

18

Environment

6

Social

22

Governance

25

Exclusion screening

Adult content

Not available

Alcoholic

Not available

Animal testing

Not available

Firearms

Not available

Tobacco

Not available

Gambling

Not available

Nuclear

Not available

Powered by illuminem

Reporting

sustainability report symbol

Sustainability Report

Available

Not committed to key sustainability initiatives

Sustainability employees


    Available in
    Scale package

    Access
  • Email

  • Email